Please provide your email address to receive an email when new articles are posted on . The numbers needed to treat to prevent return to any drinking were 11 for acamprosate and 18 for oral naltrexone ...

Data came from 118 randomized clinical trials lasting at least 12 weeks with 20,976 participants. 74% of these studies included psychosocial co-interventions, and the primary outcome was alcohol ...

People are using GLP-1s to cut back on alcohol use disorder, but there are already three FDA-approved drugs: naltrexone, acamprosate, and disulfiram.

About 8 million people fit the diagnosis of alcoholism. It is a tough addiction to beat, but a new study offers hope. Researchers studied the effectiveness of a number of different treatments in 1,400 ...

(Reuters) - Scientists researching drugs to treat alcoholism are building on an established range of treatments which target known areas of brain activity. The following overview outlines treatments ...